Figure 1
From: B2 microglobulin is a novel prognostic marker of Angioimmunoblastic T-cell lymphoma
Overall survival (a) and progression-free survival (b) of 100 patients followed up among 117 patients with angioimmunoblastic T-cell lymphoma.
Figure 1 | Scientific Reports
